Oral Mucositis Market, By Cause (Chemotherapy-Induced Oral Mucositis, Radiotherapy-Induced Oral Mucositis, Hematopoietic Stem Cell Transplantation-Induced Oral Mucositis, and Other Causes), By Treatment Type (Barrier/Coating Agents (Gels, Mouthwashes, Sprays, Films), Analgesics and Anesthetics (Topical Analgesics, Topical Anesthetics), Anti-Inflammatory Agents (Steroidal, Non-Steroidal), Antimicrobials (Antifungals, Antibacterials), Growth Factors (Palifermin), Cryotherapy Devices (Intraoral Cryotherapy Devices), Nutritional Support Products (Oral Nutritional Supplements), and Others), By Drug Type (Small Molecule Drugs, Biologics, and Biosimilars), By Severity Grade (Mild (Grade 1-2) and Severe (Grade 3-4)), By Patient Type (Pediatric, Adult, and Geriatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End User (Hospitals, Dental Clinics, Oncology Hospitals, Research and Academic Institutes, and Homecare Settings), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Growth Trends and Forecasts (2025-2032)